MacroGenics, Inc. (MGNX)
NASDAQ: MGNX · Real-Time Price · USD
4.130
+0.050 (1.23%)
At close: Aug 28, 2026, 4:00 PM EDT
4.100
-0.030 (-0.73%)
After-hours: Aug 28, 2026, 7:30 PM EDT

MacroGenics Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
175.14149.5149.9658.75151.9477.45
Revenue Growth
21.65%-0.31%155.26%-61.33%96.19%-26.16%
Gross Profit
-1.3-33.68-39.53-116.06-62.47-139.78
Operating Income
-38.06-72.84-110.58-168.24-121.42-202.8
Net Income
-14.59-74.62-66.97-9.06-119.76-202.12
Earnings Per Share
-0.23-1.18-1.07-0.15-1.95-3.37
EPS Growth
------

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
173.31189.91201.67229.81154.35243.62
Total Debt
35.0936.7637.4633.9734.8325.47
Net Cash (Debt)
138.21153.15164.21195.83119.51218.15
Net Cash Growth
-0.74%-6.73%-16.15%63.86%-45.21%-10.33%
Net Cash Per Share
2.182.422.623.161.953.64

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-63.72-81.04-68.37-78.21-86.96-143.83
Capital Expenditures
-1.82-1.91-3.71-1.76-3.62-6.2
Free Cash Flow
-65.54-82.95-72.08-79.97-90.58-150.03
Free Cash Flow Growth
------

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
-0.74%-22.53%-26.36%-197.54%-41.11%-180.49%
Operating Margin
-21.73%-48.72%-73.74%-286.38%-79.91%-261.85%
Pretax Margin
-58.14%-50.36%-44.03%-15.42%-78.82%-260.97%
Profit Margin
-8.33%-49.91%-44.66%-15.42%-78.82%-260.97%
FCF Margin
-37.42%-55.49%-48.07%-136.12%-59.62%-193.72%

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Forward PE
-23.9623.9623.9623.9623.96
PS Ratio
1.500.681.3610.162.7212.70